115 related articles for article (PubMed ID: 1419606)
21. Percentage of cells in the S phase of the cell cycle in human lymphoma determined by flow cytometry.
Braylan RC; Diamond LW; Powell ML; Harty-Golder B
Cytometry; 1980 Nov; 1(3):171-4. PubMed ID: 7021101
[TBL] [Abstract][Full Text] [Related]
22. Models of S-phase determination in lymphomas from flow cytometric DNA content histograms: comparison with the bromodeoxyuridine labeling index.
Beauregard P; Witzig TE; Kurtin PJ; Greipp PR; Stenson MJ; Katzmann JA; Habermann TM; Wieand HS
Hematol Pathol; 1991; 5(4):177-83. PubMed ID: 1794967
[TBL] [Abstract][Full Text] [Related]
23. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
[TBL] [Abstract][Full Text] [Related]
24. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
Larsson P
Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and reproducibility of the [3H]-thymidine labelling index in breast cancer. The SICCAB Group for Quality Control of Cell Kinetic Determination.
Silvestrini R
Cell Prolif; 1991 Sep; 24(5):437-45. PubMed ID: 1932355
[TBL] [Abstract][Full Text] [Related]
26. [Non-Hodgkin's lymphoma in adults: a clinico-pathologic study of 169 cases].
Ding SL; Ko WS; Hwang WS
J Formos Med Assoc; 1990 Nov; 89(11):1017-22, 1015. PubMed ID: 1982122
[TBL] [Abstract][Full Text] [Related]
27. Human immunodeficiency virus-related lymphomas: a possible association between tumor proliferation, lack of ploidy anomalies, and immune deficiency.
McDunn SH; Winter JN; Variakojis D; Rademaker AW; Von Roenn JH; Tallman MS; Gordon LI; Bauer KD
J Clin Oncol; 1991 Aug; 9(8):1334-40. PubMed ID: 1677032
[TBL] [Abstract][Full Text] [Related]
28. Prognostic indicators in centroblastic-centrocytic lymphoma.
Griffin NR; Howard MR; Quirke P; O'Brien CJ; Child JA; Bird CC
J Clin Pathol; 1988 Aug; 41(8):866-70. PubMed ID: 3170773
[TBL] [Abstract][Full Text] [Related]
29. Comparison of flow cytometric data obtained using fresh and paraffin-embedded lymphoid tissue.
Grace J; Hall B
Anal Quant Cytol Histol; 1989 Feb; 11(1):67-71. PubMed ID: 2719796
[TBL] [Abstract][Full Text] [Related]
30. [Non-Hodgkin's lymphoma].
Oguchi M; Gomi K; Shikama N
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Apr; 62(5):206-14. PubMed ID: 12043225
[TBL] [Abstract][Full Text] [Related]
31. [Flow cytometric analysis of surface phenotypes in B-cell non-Hodgkin's lymphoma].
Chubachi A
Rinsho Ketsueki; 1989 Dec; 30(12):2134-40. PubMed ID: 2516139
[TBL] [Abstract][Full Text] [Related]
32. [Non-Hodgkin's lymphomas. II. Analysis of the prognostic factors in a series of 307 patients].
García Zueco JC; Delgado MP; Giraldo MP; Perella M; Rubio-Félix D; Giralt M
Sangre (Barc); 1992 Oct; 37(5):337-44. PubMed ID: 1293772
[TBL] [Abstract][Full Text] [Related]
33. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric immunophenotyping including Bcl-2 detection on fine needle aspirates in the diagnosis of reactive lymphadenopathy and non-Hodgkin's lymphoma.
Laane E; Tani E; Björklund E; Elmberger G; Everaus H; Skoog L; Porwit-MacDonald A
Cytometry B Clin Cytom; 2005 Mar; 64(1):34-42. PubMed ID: 15669024
[TBL] [Abstract][Full Text] [Related]
35. Flow cytometric analysis of high grade B-cell non-Hodgkin's lymphoma: correlation between histology, immunophenotyping and cell cycle analysis.
Lackowska B; Wasilewska A; Gruchała A; Ryś J; Szklarski W; Niezabitowski A
Pol J Pathol; 1994; 45(4):271-4. PubMed ID: 7697328
[TBL] [Abstract][Full Text] [Related]
36. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
Crocker J; Macartney JC; Smith PJ
J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
[TBL] [Abstract][Full Text] [Related]
37. Extranodal non-Hodgkin's lymphomas--a retrospective review of clinico-pathologic features and outcomes in comparison with nodal non-Hodgkin's lymphomas.
Lal A; Bhurgri Y; Vaziri I; Rizvi NB; Sadaf A; Sartajuddin S; Islam M; Kumar P; Adil S; Kakepoto GN; Masood N; Khurshed M; Alidina A
Asian Pac J Cancer Prev; 2008; 9(3):453-8. PubMed ID: 19004134
[TBL] [Abstract][Full Text] [Related]
38. Fraction of S-phase cells in blood mononuclear cells in non-Hodgkin's lymphomas--correlation with clinical features and prognosis.
Lindh J; Jonsson H; Lenner P; Roos G
Eur J Haematol; 1989 Apr; 42(4):331-8. PubMed ID: 2785930
[TBL] [Abstract][Full Text] [Related]
39. Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
Klemi PJ; Alanen K; Jalkanen S; Joensuu H
Br J Cancer; 1992 Oct; 66(4):739-43. PubMed ID: 1358164
[TBL] [Abstract][Full Text] [Related]
40. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
Korkolopoulou P; Oates J; Kittas C; Crocker J
J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
